Irving Investors

Navan is a company that specializes in corporate travel management, expense management, and corporate card solutions, aimed at automating manual processes and enhancing spend visibility. By integrating advanced technologies such as cloud computing, mobile applications, and artificial intelligence, Navan offers a modern approach to managing travel and expenses. The platform provides real-time data to help organizations maintain traveler safety and control costs while ensuring a seamless booking experience. Through its innovative services, Navan seeks to simplify travel itinerary management and improve efficiency for businesses, ultimately saving both time and money.

Caris Life Sciences is a biosciences company that focuses on improving cancer patient outcomes through advanced molecular profiling and diagnostic technologies. It specializes in various areas of pathology, including oncology, dermatopathology, hematopathology, gastrointestinal pathology, and urologic pathology. The company offers a range of services, including prognostic testing, genomic profiling, transcriptomic and proteomic analyses, and the Comprehensive Oncology Data Explorer, a clinico-genomic data platform. By utilizing artificial intelligence and machine learning, Caris Life Sciences analyzes complex molecular data to aid healthcare providers in making informed treatment decisions. The company, founded in 1987 and headquartered in Irving, Texas, serves a global clientele through distributors in the United States, Europe, and Australia, and has additional offices in Phoenix and Basel. Caris Life Sciences also collaborates with various partners to enhance its offerings and expand its impact in the field of personalized medicine.

OpenAI is an artificial intelligence research and deployment company focused on developing machine learning technologies that aim to create safe artificial general intelligence for the benefit of all users. The company engages in projects related to autonomous learning and task performance across various industries, including technology, healthcare, and education. OpenAI's platform directs artificial intelligence applications and is involved in policy work, education, and outreach, enabling clients to enhance their skills and knowledge while leveraging autonomous systems that can surpass human performance in economically valuable tasks.

Turo Inc. operates an online peer-to-peer car rental marketplace that connects local car owners with travelers seeking to rent vehicles. Founded in 2009 and based in San Francisco, California, the platform allows owners to list their cars for rent, offering a diverse selection of vehicles at competitive prices. Travelers can choose from various options for local pickup, city delivery, and airport delivery. This model not only provides convenient access to cars for renters but also enables owners to generate income from their vehicles. Turo aims to create a community of trusted hosts and guests, facilitating a seamless car-sharing experience.

Attentive is a leader in conversational commerce, offering a personalized mobile messaging platform that facilitates communication between businesses and consumers. The platform leverages behavioral data to enable brands to send automated, tailored messages throughout the customer lifecycle, including product recommendations, promotions, and real-time customer support. By focusing on SMS communication, Attentive helps entrepreneurs and enterprises engage more effectively with their customers, enhancing relationships and driving sales in the e-commerce and retail sectors.

OneTrust, LLC is a technology company that specializes in privacy management and compliance solutions, assisting organizations in adhering to global regulations. Founded in 2016 and headquartered in Atlanta, Georgia, OneTrust offers a comprehensive platform that automates privacy impact assessments, data inventory mapping, and risk remediation actions. Its solutions cover a wide range of needs, including vendor risk management, incident reporting, and website compliance, helping businesses manage privacy risks associated with customer, employee, and vendor data. The platform enables collaboration among privacy professionals and business groups, facilitating continuous compliance through recurring audits and assessments. OneTrust serves a diverse clientele, from multinational corporations to small and medium enterprises, and operates additional offices in various global locations, including London, São Paulo, and Bengaluru.

Databricks Inc. offers a unified data analytics cloud platform that simplifies data engineering and supports collaborative data science. Its core product, Databricks, enables organizations to process and analyze large datasets efficiently, leveraging tools like Apache Spark. The platform is designed for real-time experimentation and robust deployment of production applications, catering to developers and data scientists. Additionally, Databricks provides Databricks Delta, a data management system that combines the scalability of a data warehouse with low-latency streaming capabilities. The company also offers MLflow for managing the machine learning lifecycle and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including healthcare, finance, manufacturing, and telecommunications. Founded in 2013 and headquartered in San Francisco, with additional offices in London, Amsterdam, and Bengaluru, Databricks has established strategic partnerships to enhance its offerings and foster innovation in data and AI technologies.

Celonis specializes in execution management, focusing on helping companies optimize their business processes through its advanced process mining technology. The company's core offering, the Celonis Execution Management System (EMS), provides a comprehensive suite of tools and applications that assist organizations in managing various aspects of execution, from analytics and strategy to planning, management, and automation. By leveraging its unique software solutions, Celonis enables businesses across industries such as production, human resources, and logistics to enhance productivity, improve process transparency, and increase operational efficiency. The emphasis on analyzing and optimizing online business processes positions Celonis as a key player in the field of management consultancy and automation.

Icertis is a cloud-based enterprise contract management platform that addresses complex contract management challenges through an intuitive interface. Founded in 2009 and headquartered in Bellevue, Washington, Icertis utilizes artificial intelligence to analyze and structure various types of contracts, helping organizations streamline their processes. The platform enhances contract velocity, ensures compliance with regulatory and policy requirements, and optimizes commercial relationships by maximizing revenue and minimizing costs. By providing detailed risk reports and automating the management of obligations, Icertis enables clients to improve governance, mitigate risks, and boost overall productivity.

Snyk Ltd. is a software as a service company that provides a platform for identifying, fixing, and monitoring vulnerabilities in applications. Founded in 2015 and headquartered in London, with additional offices in Tel Aviv, Boston, and Ontario, Snyk offers a range of solutions tailored for developers and security teams. Its key products include Snyk Code, a developer-first static application security testing tool, and container vulnerability management for securing Docker images. The platform also supports application security management, licensing compliance, and infrastructure as code security, ensuring that all components of modern applications are secure. Snyk’s Developer Security Platform integrates seamlessly into developers' workflows, promoting collaboration between development and security teams. The company serves over 1,200 customers globally, including notable organizations like Google and Salesforce, and has formed a strategic partnership with Rapid7. Snyk is recognized for its contributions to enhancing application security in an increasingly digital landscape.

Chainalysis Inc. is a blockchain analysis company that specializes in developing anti-money laundering software for cryptocurrency businesses. Founded in 2014 and headquartered in New York, with additional offices in Copenhagen, Tokyo, and Singapore, the company offers a range of products to enhance compliance and security in the cryptocurrency sector. Its primary tools include REACTOR, an interactive investigation tool that helps identify offenders and visualize data, and an API that provides transaction-based risk scoring by tracking the source and destination of funds. Chainalysis also provides activity monitoring reports and due diligence tools that assist financial institutions in assessing risks, estimating potential criminal revenues, and identifying emerging threats. The company serves a diverse clientele, including government agencies, banks, exchanges, insurance firms, and various cryptocurrency businesses, facilitating safer interactions within the decentralized finance landscape.

Klaviyo, Inc. is a technology company that specializes in email marketing and marketing automation solutions tailored for businesses, particularly in the eCommerce sector. Founded in 2012 and headquartered in Boston, Massachusetts, with an additional office in London, Klaviyo offers a software-as-a-service (SaaS) platform that enables users to create personalized marketing experiences. The platform features tools for email campaigns, including automated messages for abandoned carts and customer follow-ups, as well as advanced analytics and segmentation capabilities. Klaviyo integrates seamlessly with various customer data sources, allowing businesses to manage their marketing efforts efficiently and effectively measure performance. By leveraging machine learning and artificial intelligence, Klaviyo helps businesses optimize their marketing strategies and drive growth through targeted communication. Revenue is generated through subscription sales for access to the platform.

Leap enables brands to deploy modern, immersive retail stores that drive growth and acquire customers. By leveraging millions of data points and a platform strategy, Leap makes physical retail more productive and less risky for brands. Its platform also follows a technology-enabled approach and includes all aspects of store development and operations, including physical space, staffing, and managing all technology infrastructure that helps consumer brands to grow and deepen their customer brand experience. The company was founded in 2018 and is headquartered in Chicago, Illinois.

Metagenomi, Inc. is a biotechnology company focused on developing gene editing systems aimed at treating genetic diseases. Founded in 2016 and based in Emeryville, California, Metagenomi utilizes metagenomics and machine learning to uncover novel genome editing technologies derived from previously uncharacterized organisms. The company's innovative discovery platform enables the creation of highly efficient and specific gene editing tools, including programmable nucleases, base editors, and advanced integration systems such as prime editing and CRISPR-associated transposases. By harnessing these naturally evolved systems, Metagenomi seeks to address a wide range of genetic mutations that traditional genome engineering approaches have struggled to target, with the ultimate goal of providing transformative therapies for patients globally.

Checkr, Inc. is a technology company specializing in the background check industry. Founded in 2014 and headquartered in San Francisco, California, Checkr offers a range of screening services, including criminal record checks, driving checks, and identity verification. The company utilizes advanced technology, including artificial intelligence and machine learning, to deliver faster and more efficient background checks compared to traditional providers. Its platform not only enhances hiring transparency and fairness but also assists businesses in complying with regulations and improving operational efficiency. Checkr serves various sectors, including financial services, healthcare, retail, and technology, providing solutions that cater to the evolving needs of the workforce.

Arctic Wolf Networks, Inc. is a cybersecurity company that provides security operations center-as-a-service to businesses, enabling them to manage and mitigate cyber risks effectively. The company offers a range of services, including cloud infrastructure monitoring, software-as-a-service application monitoring, vulnerability assessments, and account takeover risk detection. It also develops the Arctic Wolf Agent, a software tool that collects actionable intelligence from IT environments. Serving industries such as financial services, healthcare, and legal, Arctic Wolf employs a concierge security model, where its engineers work closely with clients to deliver tailored threat detection, response, and ongoing risk management. Founded in 2012 and headquartered in Eden Prairie, Minnesota, the company also has offices in Provo, Utah, and Waterloo, Canada.

DNA Script is a pioneering company in the field of DNA synthesis, focused on enhancing life science and human health through innovative technology. The company has developed a unique enzymatic process that allows for the production of synthetic DNA using natural enzymes. This technology underpins their benchtop DNA printer, SYNTAX, which enables laboratories to synthesize their own oligonucleotides. By doing so, DNA Script provides researchers with greater control over their workflows, facilitating faster access to essential genomic materials for various applications in molecular biology and genomics. This capability accelerates experimentation and supports the development of new therapeutics, positioning DNA Script as a key player in the biotechnology sector.

Bombas is an apparel brand founded in 2013 in New York, specializing in the manufacture of high-quality athletic socks for men, women, teens, and girls. The company also offers a range of other products, including underwear and t-shirts. Through its online platform, Bombas provides customers with comfortable, soft, and durable apparel at affordable prices. In addition to its focus on quality, the brand is committed to social responsibility, donating one item for every item sold to those in need.

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients. Its proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity. The company was founded in 2020 and is headquartered in La Jolla, CA, USA.

InterVenn is a life science company focused on glycoproteomics, the study of glycosylated proteins that play a crucial role in protein function. The company's pioneering AI-powered platform aims to decode the glycoproteome, which contains vital information about human biology, thereby enhancing patient outcomes. InterVenn's technology facilitates the identification, quantification, and classification of glycoproteomic signals found in blood and tissue, enabling early detection and diagnosis of cancers, particularly ovarian cancer. This platform not only supports clinical applications such as disease screening and diagnostics but also offers valuable insights for pharmaceutical partners involved in research and development. Founded by notable scientists, including Nobel Laureate Dr. Carolyn Bertozzi, InterVenn is positioned to advance personalized, predictive, and preventative healthcare solutions.

Genomatica, Inc. is a biotechnology company based in San Diego, California, that specializes in developing manufacturing processes to produce intermediate and basic chemicals from renewable feedstocks. Utilizing a proprietary platform, the company creates fermentation-based processes and engineers microorganisms that facilitate the conversion of these feedstocks into valuable chemicals. Genomatica has commercialized processes for butanediol, used in biodegradable plastics and apparel, and butylene glycol, which is utilized in cosmetics and personal care products. The company is also advancing the development of bio-nylon and has a pipeline targeting the production of 20 different chemicals, including butadiene. Recognized for its innovative technology, Genomatica has received several awards, including the Kirkpatrick Award for notable chemical engineering advancements and the ICIS Innovation Award for its Brontide butylene glycol.

Cybereason Inc. is a cybersecurity company specializing in endpoint protection through its advanced platform that offers endpoint detection and response, next-generation antivirus, and anti-ransomware solutions. Founded in 2012 and headquartered in Boston, Massachusetts, with additional offices in London, Tel Aviv, and Tokyo, Cybereason's platform utilizes a custom-built in-memory graph to automate the detection of behavioral patterns across endpoints. This technology allows organizations to identify and respond to cyber threats effectively by revealing the full scope of an attack and enabling rapid response actions. The company's product offerings include solutions for behavioral data analysis, advanced attack prevention, and threat investigation, alongside managed monitoring and incident response services. Cybereason's focus is on providing enterprises with the tools needed to outmaneuver cyber adversaries.

BioTheryX, Inc. is a clinical-stage biopharmaceutical company based in Chappaqua, New York, focused on developing innovative therapies that restore protein homeostasis through targeted protein degradation. The company specializes in Protein Homeostatic Modulators and small molecule targeted protein degraders (TPDs), which utilize a unique mechanism involving molecular glues to regulate protein levels within the body. Their proprietary PRODEGY platform is built on a library of Cereblon binders, enabling the design of bifunctional and hybrid degraders aimed at treating various diseases, particularly cancer. BioTheryX's lead candidate, BTX-A51, is an oral small molecule and multi-kinase inhibitor targeting specific leukemic stem cells and oncogenic transcription factors. Established in 2007, BioTheryX aims to address significant unmet medical needs by leveraging its expertise in protein modulation and degradation.

LUMICKS specializes in advanced technologies for studying biology and cancer at the single-molecule and single-cell levels. The company focuses on bridging the gap between molecular structure and function, providing tools that enable real-time analysis of complex biological processes. Its flagship product, the C-Trap Optical Tweezers, combined with Fluorescence Microscopy, allows scientists to observe interactions at the single-molecule level. Additionally, the z-Movi Cell Avidity Analyzer measures and selects immune cells based on their real-time interactions with target cells. By facilitating live measurement and imaging, LUMICKS' instruments provide critical insights into the fundamental causes of diseases, including cancer, and hold potential for optimizing drug development.

Crossover Health, Inc. provides comprehensive workplace healthcare services tailored for employers and their employees. Founded in 2010, the company is headquartered in Aliso Viejo, California, with health centers located in various regions, including Silicon Valley. Crossover Health offers a wide range of services, including primary care, urgent care, chronic disease management, preventive care, health risk assessments, and health education. Additionally, it provides ancillary services such as physical therapy, chiropractic care, acupuncture, and care coordination, along with health analytics and remote care options. The company's focus is on creating a positive employee care experience that promotes a healthy and motivated workforce while delivering financial benefits to organizations.

Absci is a drug and target discovery company that utilizes deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. By employing its Integrated Drug Creation Platform, Absci identifies novel drug targets and discovers optimal biotherapeutic candidates while simultaneously generating the necessary cell lines for manufacturing. This innovative approach allows biotech and pharmaceutical partners to develop next-generation protein-based drugs, including Bionic Proteins that incorporate nonstandard amino acids and other unique drug designs that may be unattainable through traditional methods. Absci's mission focuses on advancing the development of improved medicines by effectively translating innovative ideas into viable drugs.

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale. Model Medicines harnesses AI and ML with its ActivPred AI Drug Discovery Platform to discover drugs that may be repositioned to serve as therapeutics to treat patients suffering from humankind’s toughest diseases. The drugs that Model Medicines discovers can enter clinical trials in as little as several months.

NexImmune, Inc. is a clinical-stage biopharmaceutical company based in Gaithersburg, Maryland, specializing in the development of innovative immuno-therapeutics utilizing its proprietary Artificial Immune (AIM) technology. This technology is designed to enhance the immune system's ability to generate specific responses to targeted antigens, which is crucial for effective cancer treatment and other immune-mediated diseases. NexImmune's product offerings include AIM101, an injectable therapy for certain solid tumors, and AIM ACT, an adoptive cellular therapy aimed at treating specific hematological malignancies. The company is currently advancing two product candidates in human trials: NEXI-001 for acute myeloid leukemia and NEXI-002 for multiple myeloma. By focusing on improving the body's T cell responses, NexImmune aims to provide curative therapies for patients facing life-threatening conditions.

Imago BioSciences is a clinical-stage biotechnology company based in Redwood City, California, that specializes in developing innovative medicines for hematologic diseases. Founded in 2012, the company focuses on therapeutics that target genetic and epigenetic factors, specifically through the inhibition of lysine-specific demethylase 1 (LSD1), an enzyme crucial in blood cell production. Imago BioSciences aims to address significant medical challenges associated with conditions such as leukemia, myelodysplastic syndrome, and other bone marrow disorders. Its lead product candidate, Bomedemstat, is an orally available small molecule designed to treat certain myeloproliferative neoplasms, with the goal of altering disease progression and improving the quality and longevity of patients' lives.

Prometheus Biosciences, formerly known as Prometheus Laboratories, is a specialty pharmaceutical company headquartered in San Diego, California. The company develops and commercializes innovative pharmaceutical and diagnostic products aimed at enhancing individualized patient care, particularly in the fields of gastroenterology and autoimmune diseases. Prometheus offers a range of diagnostic tests, including assays for monitoring drug and anti-drug antibody levels, as well as tests for inflammatory bowel disease and celiac disease. Among its marketed products are Entocort EC, indicated for Crohn's disease, and Imuran, used in kidney transplantation and rheumatoid arthritis management. Additionally, the company is involved in developing new treatments, such as COLAL-PRED, for gastrointestinal disorders. Through its advanced diagnostics and therapeutic offerings, Prometheus Biosciences assists healthcare providers in optimizing treatment strategies and improving patient outcomes.

Nuvation Bio Inc. is a biopharmaceutical company dedicated to developing innovative therapies for oncology, addressing unmet medical needs in the treatment of challenging cancers that have not responded to conventional therapies. Founded in 2018 and based in New York, with an additional office in San Francisco, the company has a portfolio of drug development candidates aimed at improving patient outcomes. One of its key clinical-stage candidates is NUV-868, an oral small molecule BET inhibitor that targets the BRD4 protein, which plays a crucial role in regulating tumor growth and differentiation. Additionally, Nuvation Bio is advancing its proprietary small molecule Drug-Drug Conjugate platform, further expanding its therapeutic arsenal in oncology.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders that involve neuronal imbalance. The company is advancing several lead product candidates, including PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator currently in Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective small molecule inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is developing PRAX-562, a persistent sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, as well as PRAX-222, an antisense oligonucleotide targeting SCN2A epilepsy. The company also has a program for treating KCNT1 gain-of-function epilepsy. Established in 2015 and based in Cambridge, Massachusetts, Praxis collaborates with other organizations through various agreements to enhance its research and development efforts.

Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease. It is integrating breakthroughs in kidney genetics and biology to identify new therapeutic targets and advance first-in-class drug candidates to treat patients with kidney disease. Its Product Engine will industrialize the integration of genetics and kidney biology and confer a differentiated ability to identify, validate, and pursue novel therapeutic targets to treat progressive kidney disease. The company was founded in 2016 and is based in Cambridge, Massachusetts.

Rubrik offers live data access for recovery and application development by fusing enterprise data management with web-scale IT and eliminating backup software. This marks the end of a decade-long innovation drought in backup and recovery, the backbone of IT. Within minutes, businesses can manage the explosion of data across private and public clouds.

FAASOS is a food service brand that operates primarily as a cloud kitchen, focusing on on-demand food delivery. It specializes in delivering meals through its in-house brands while also utilizing a dark-kitchen model to efficiently prepare and distribute food. By leveraging advanced technology and culinary expertise, FAASOS ensures high food quality and a diverse menu for consumers. The brand aims to enhance the dining experience by offering a variety of options from nearby restaurants, making it convenient for customers to enjoy their favorite meals at home. Through its innovative approach, FAASOS positions itself as a key player in the evolving food delivery market.

ThredUp Inc. is an online consignment and thrift store specializing in the resale of women's and children's apparel, shoes, and accessories. Founded in 2009 and headquartered in Oakland, California, ThredUp operates one of the largest resale platforms globally, promoting a sustainable shopping model by making it easy for consumers to buy and sell secondhand items. The company generates revenue through sales on its website and mobile app, as well as partnerships with retail-as-a-service providers. With a mission to encourage consumers to prioritize secondhand shopping, ThredUp aims to extend the life cycle of clothing and transform the fashion industry towards a more sustainable future.

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies to overcome resistance in cancer treatments. Founded in 2014 and based in South San Francisco, the company’s lead product candidate, ORIC-101, is a small molecule antagonist of the glucocorticoid receptor, which is associated with resistance to various cancer therapies in solid tumors. Its second candidate, ORIC-533, is an orally bioavailable small molecule inhibitor of CD73, targeting a critical component of the adenosine pathway linked to resistance against chemotherapy and immunotherapy. In addition to these products, ORIC is advancing multiple precision medicines aimed at addressing other mechanisms of cancer resistance. The company’s founders, Charles Sawyers and Scott Lowe, have extensive experience in identifying novel cancer targets that have led to innovative therapies.

FAASOS is a food service brand that operates primarily as a cloud kitchen, focusing on on-demand food delivery. It specializes in delivering meals through its in-house brands while also utilizing a dark-kitchen model to efficiently prepare and distribute food. By leveraging advanced technology and culinary expertise, FAASOS ensures high food quality and a diverse menu for consumers. The brand aims to enhance the dining experience by offering a variety of options from nearby restaurants, making it convenient for customers to enjoy their favorite meals at home. Through its innovative approach, FAASOS positions itself as a key player in the evolving food delivery market.

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order.By manipulating this system with our unique Gene Traffic ControlTM platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease.With Gene Traffic ControlTM Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.

Pearl is an AI-driven company focused on enhancing patient care within the dental field through its FDA-cleared technology. This advanced system is capable of identifying dental diseases in X-rays while recognizing various dental pathologies and natural anatomical features. By providing practitioners with robust data, Pearl's technology allows for improved patient interactions and better treatment options. Additionally, the company has developed a suite of solutions designed to automate tasks in dental laboratories, thereby increasing efficiency and precision in dental healthcare for clinicians, practice owners, labs, and insurers.

PAX Labs, Inc. is a manufacturer of premium vaporizers and accessories designed for loose-leaf and concentrates. The company's product lineup includes the PAX 3, PAX 2, and PAX Era, along with various accessories and a mobile application that enhances user experience. PAX Labs aims to simplify cannabis consumption by providing products that emphasize quality, transparency, and predictability. The company distributes its products through a network of retailers and distributors across the United States and internationally, as well as through its online platform. Founded in 2004 and headquartered in San Francisco, California, PAX Labs has established itself as an industry leader through innovation and thoughtful product design.

Dixie Brands is a prominent producer of innovative cannabis products, established in 2010 following Colorado's legalization of medical marijuana. The company specializes in crafting a variety of THC-infused offerings, including beverages, edibles, tinctures, concentrates, and topicals, all designed to provide accurate dosing and enjoyable consumption. Dixie utilizes a meticulous process that involves CO2 extraction and triple lab testing to ensure the quality and safety of its products. With a commitment to research, education, and advocacy, Dixie Brands aims to lead the cannabis industry by providing effective and delicious options for consumers. As a pioneer in the sector, the company was the first to receive an Infused Products Retail Marijuana License, solidifying its reputation as a trusted source for premium cannabis-infused items.

GOAT is a global marketplace specializing in authentic sneakers, apparel, and accessories from contemporary luxury brands. Founded in 2015 and headquartered in Los Angeles, the platform connects buyers and sellers, allowing users to make offers on desired styles and access exclusive drops. GOAT features a wide selection of over 350 brands, leveraging innovative technology to ensure product authenticity and enhance the sneaker commerce experience. With thirteen physical locations across the United States, Asia, and Europe, the company operates distribution and authentication centers that serve 170 international markets. GOAT caters to a community of over 20 million members in 164 countries, positioning itself uniquely between the primary and resale markets to deliver authentic products from past, present, and future styles.

Rumble offers boxing-inspired fitness classes for a full-body strength and conditioning workouts crafted around specially designed water-filled, teardrop-style boxing bags. Rumble incorporates the best principles of the sweet science of boxing and strength training, all to help you develop that lean, strong, and confident fighter's physique. Rumble is HIIT (High-Intensity Interval Training), strength training, metabolic conditioning (METCON), and uppercut throwing cardio in one clean class.

Anaplan, Inc. offers a cloud-based connected planning platform that enables organizations to unify disparate data structures across various business functions, including finance, sales, supply chain, marketing, human resources, and operations. Founded in 2008 and headquartered in San Francisco, Anaplan provides its services through a subscription model, allowing users to access its platform over the Internet. The company focuses on enhancing decision-making and collaboration within organizations by delivering business planning and performance management solutions from a single hub. In addition to its core platform, Anaplan offers professional services, including consulting, implementation, training, and planning transformation advisory services. With operations in multiple countries and a network of expert partners, Anaplan supports large and fast-growing organizations in streamlining their planning processes and making informed decisions.

Bombas is an apparel brand founded in 2013 in New York, specializing in the manufacture of high-quality athletic socks for men, women, teens, and girls. The company also offers a range of other products, including underwear and t-shirts. Through its online platform, Bombas provides customers with comfortable, soft, and durable apparel at affordable prices. In addition to its focus on quality, the brand is committed to social responsibility, donating one item for every item sold to those in need.

GOAT is a global marketplace specializing in authentic sneakers, apparel, and accessories from contemporary luxury brands. Founded in 2015 and headquartered in Los Angeles, the platform connects buyers and sellers, allowing users to make offers on desired styles and access exclusive drops. GOAT features a wide selection of over 350 brands, leveraging innovative technology to ensure product authenticity and enhance the sneaker commerce experience. With thirteen physical locations across the United States, Asia, and Europe, the company operates distribution and authentication centers that serve 170 international markets. GOAT caters to a community of over 20 million members in 164 countries, positioning itself uniquely between the primary and resale markets to deliver authentic products from past, present, and future styles.

Instacart is a prominent grocery delivery service operating in the United States and Canada, facilitating rapid deliveries of groceries and home essentials, often within an hour. The company partners with a variety of local and national grocers, including well-known brands such as Safeway, Whole Foods, and Costco, allowing customers to select from over 500,000 items and combine orders from multiple stores. Instacart employs a network of approximately 600,000 independent contractors who pick and deliver items directly to customers' homes. In addition to its delivery services, Instacart generates revenue by charging fees based on order value and by offering advertising opportunities primarily to consumer-packaged goods companies. With nearly 8 million monthly active users, Instacart has established itself as a leading platform in the grocery delivery market.

Lyft is a transportation company that operates a mobile application designed to connect drivers with passengers seeking rides. Founded in 2013, it has become the second-largest ride-sharing service provider in the United States and Canada. The Lyft app allows users to request various types of rides, including private, shared, and luxury options, while also facilitating payment. In addition to ride-sharing, Lyft has expanded its services to include bike and scooter-sharing, promoting multimodal transportation solutions. The company primarily focuses on serving college, university, and corporate communities, and it enables riders to schedule rides up to seven days in advance.